Netherlands· NL-7b38c7a7041f
Migrafin, poeder voor oraal gebruik
A metoclopramide product containing lysineacetylsalicylaat + metoclopramidehydrochloride 1-water, registered in Netherlands by EU-Pharma B.V.. The same ATC class is registered in 19 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Metoclopramide is registered in 19 of 19 countries.
Countries holding a registration under ATC A03FA01 (metoclopramide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Metoclopramide · ATC A03FA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of metoclopramide costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.19 in France to $0.93 in Switzerland — a ×4.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Metoclopramide · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.93
- ES Spain$0.22
- FR France$0.19
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LYSINEACETYLSALICYLAAT + METOCLOPRAMIDEHYDROCHLORIDE 1-WATER
- Manufacturer
- EU-Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- A03FA01
- ATC class
- Metoclopramide
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id29779//18026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
795 interactions on record for metoclopramide.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metoclopramide · interactions on record
795 records
- 50 severe
- 323 moderate
- 9 minor
- 410 info
Most severe, free to view
- ThiethylperazinA04AB03severe
- TriflupromazinA04AD06severe
- DroperidolN01AX01severe
- Sodium oxybateN01AX11severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A03FA01
Metoclopramide, as other registers publish it.
- IcelandAfipranOrifarm Healthcare A/S
- NorwayAfipranOrifarm Healthcare A/S
- NorwayAfipranOrifarm Healthcare A/S
- NorwayAfipranOrifarm Healthcare A/S
- IcelandAfipranOrifarm Healthcare A/S
- GermanyCeolatG.L. Pharma Gmbh
- CzechiaCERUCALTeva Pharmaceuticals CR, s.r.o., Praha
- FranceCHLORHYDRATE DE METOCLOPRAMIDE RENAUDIN 10 mg/2 mL, solution injectable en ampouleLABORATOIRE RENAUDIN
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af9c3842-2e8d-4375-b1eb-fecc8025ee9f GET /v1/drugs/af9c3842-2e8d-4375-b1eb-fecc8025ee9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oraal gebruik",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h18026_smpc.pdf",
"strength": null,
"atc_label": "Metoclopramide#N02BA51 - Acetylsalicylic Acid, Comb. Excl. Psycholeptics",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29779",
"excipients": [
"ASPARTAAM (E 951)",
"CITROENSMAAKSTOF",
"GLYCINE (E 640)"
],
"substances": [
"LYSINEACETYLSALICYLAAT",
"METOCLOPRAMIDEHYDROCHLORIDE 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29779.pdf",
"authorised_at": "2003/07/22",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "29779//18026",
"additional_monitoring": "N"
}See everything about metoclopramide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.